Select Page
AstraZeneca Diabetes Drug Given FDA Approval for Children

AstraZeneca Diabetes Drug Given FDA Approval for Children

AstraZeneca has been granted FDA approval for its once-weekly diabetes medicine Bydureon (exenatide) to treat children (aged 10-18) with type-2 diabetes. The drug, an injectable suspension, aims to lower blood sugar rates. The approval is based on a late-stage study...
AstraZeneca-Oxford COVID-19 Vaccine is Granted EUA by WHO

AstraZeneca-Oxford COVID-19 Vaccine is Granted EUA by WHO

The World Health Organization (WHO) announced yesterday (2/15) its approval of emergency use authorization (EUA) of the AstraZeneca-Oxford COVID-19 vaccine. The vaccine is currently approved in the UK and EU, and the WHO’s approval opens more doors for other nations...